Boundless Bio (BOLD) Stock Price, Quote, News & History

Comments

Boundless Bio Inc (BOLD) Stock Price, Quote, News & History

BOLDNASDAQ

Trade with Public

$1.58

-0.05-3.07%

At close: Apr 17, 5:00 PM EST

$1.66

0.07884.99%

After Hours: 7:07 PM EST

OverviewNews Earnings Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

$1.64

Close

$1.58

Volume / Avg.

352.29K / 222.20K

Day Range

$1.57 - $1.65

52 Wk Range

0.96 - 1.78

Market Cap

$37.17M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

82

Short Interest

0.12%

Days to Cover

1

Recent Boundless Bio Inc News

The Daily Biotech Pulse: Xeris Jumps On Positive Data, Mixed Results For Merck's Keytruda-Chemo Combo In Lung Cancer, Intra-Cellular Announces Offering

Shanthi Rexaline

The Daily Biotech Pulse: Flexion Receives FDA Nod For Zilretta Label Expansion, Astellas Goes Shopping

Shanthi Rexaline

The Daily Biotech Pulse: European Nod For Amgen, miRagen Overhauls Clinical Pipeline, Tonix Snags Patent Win

Shanthi Rexaline

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-46.66M

Investing Cash Flow (TTM)

37.80M

Financing Cash Flow (TTM)

141.00K

Free Cash Flow (TTM)

-47.21M

Capital Expenditure (TTM)

-546.00K

Net Change in Cash (TTM)

-8.72M

Analyst Rating and Forecast

3.1

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

-$22.02M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

0.37

Earnings Yield % (TTM)

-159.51%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$4.40

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$17.87M

Debt to Equity

0.50

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$1.64

Close

$1.58

Volume / Avg.

352.29K / 222.20K

Day Range

$1.57 - $1.65

52 Wk Range

0.96 - 1.78

Market Cap

$37.17M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

82

Short Interest

0.12%

Days to Cover

1

About

Sector

Health Care

Industry

Biotechnology

Boundless Bio Inc is a clinical-stage oncology company. It is focused on developing cancer therapeutics that address the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplifi...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Boundless Bio (BOLD) stock?

A

You can purchase shares of Boundless Bio (NASDAQ:BOLD) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Boundless Bio (BOLD) competitors?

A

Other companies in Boundless Bio’s space includes: Evaxion AS (NASDAQ:EVAX), Sensei Biotherapeutics Inc (NASDAQ:SNSE), Palatin Technologies Inc (AMEX:PTN), Edesa Biotech Inc (NASDAQ:EDSA) and ABVC BioPharma Inc (NASDAQ:ABVC).

Q

What is the forecast, or price target, for Boundless Bio (BOLD) stock?

A

Boundless Bio has a consensus price target of $8.00.

Q

What is the current price for Boundless Bio (BOLD)?

A

The stock price for Boundless Bio (NASDAQ: BOLD) is $1.6588 last updated April 17, 2026 at 7:07 PM EDT.

Q

Does Boundless Bio (BOLD) pay a dividend?

A

There are no upcoming dividends for Boundless Bio.

Q

When is Boundless Bio (NASDAQ:BOLD) reporting earnings?

A

Boundless Bio does not have any upcoming earnings scheduled.

Q

Is Boundless Bio (BOLD) going to split?

A

There is no upcoming split for Boundless Bio.

Q

What sector and industry does Boundless Bio (BOLD) operate in?

A

Boundless Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch

Sensei Biotherapeutics Inc

NASDAQ:SNSE

$30.39

-0.33%

Palatin Technologies Inc

Lisata Therapeutics Inc

Key Statistics

Open

$1.64

Close

$1.58

Volume / Avg.

352.29K / 222.20K

Day Range

$1.57 - $1.65

52 Wk Range

0.96 - 1.78

Market Cap

$37.17M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

82

Short Interest

0.12%

Days to Cover

1

Recent Boundless Bio Inc News

The Daily Biotech Pulse: Xeris Jumps On Positive Data, Mixed Results For Merck's Keytruda-Chemo Combo In Lung Cancer, Intra-Cellular Announces Offering

Shanthi Rexaline

The Daily Biotech Pulse: Flexion Receives FDA Nod For Zilretta Label Expansion, Astellas Goes Shopping

Shanthi Rexaline

The Daily Biotech Pulse: European Nod For Amgen, miRagen Overhauls Clinical Pipeline, Tonix Snags Patent Win

Shanthi Rexaline

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-46.66M

Investing Cash Flow (TTM)

37.80M

Financing Cash Flow (TTM)

141.00K

Free Cash Flow (TTM)

-47.21M

Capital Expenditure (TTM)

-546.00K

Net Change in Cash (TTM)

-8.72M

Analyst Rating and Forecast

3.1

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

-$22.02M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

0.37

Earnings Yield % (TTM)

-159.51%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$4.40

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$17.87M

Debt to Equity

0.50

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$1.64

Close

$1.58

Volume / Avg.

352.29K / 222.20K

Day Range

$1.57 - $1.65

52 Wk Range

0.96 - 1.78

Market Cap

$37.17M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

82

Short Interest

0.12%

Days to Cover

1

About

Sector

Health Care

Industry

Biotechnology

Boundless Bio Inc is a clinical-stage oncology company. It is focused on developing cancer therapeutics that address the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplifi...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry